Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder
Robert Suchting, Jin H. Yoon, Guadalupe G. San Miguel, et al.
Brain Research (2019) Vol. 1731, pp. 146359-146359
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H. James, Jennifer E. Fragale, R. Nisha Aurora, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 5, pp. 717-719
Open Access | Times Cited: 51
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Sleep loss and addiction
Luis Angel López-Muciño, Fabio García‐García, Jonathan Cueto‐Escobedo, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104832-104832
Closed Access | Times Cited: 26
The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System
Jennifer E. Fragale, Morgan H. James, Jorge A. Avila, et al.
Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences (2021), pp. 117-127
Open Access | Times Cited: 29
Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis
Mengzhen Zhou, Jiyou Tang, Shasha Li, et al.
Frontiers in Human Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse
Morgan H. James, Jennifer E. Fragale, Shayna L. O’Connor, et al.
Neuropharmacology (2020) Vol. 183, pp. 108359-108359
Open Access | Times Cited: 29
Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior
Natalie E. Zlebnik, Nathan A. Holtz, Victoria C. Lepak, et al.
Drug and Alcohol Dependence (2021) Vol. 224, pp. 108719-108719
Open Access | Times Cited: 24
New directions in modelling dysregulated reward seeking for food and drugs
Robyn M. Brown, Christopher V. Dayas, Morgan H. James, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 1037-1048
Open Access | Times Cited: 23
Oxytocin and orexin systems bidirectionally regulate the ability of opioid cues to bias reward seeking
Giuseppe Giannotti, Francesca Mottarlini, Jasper A. Heinsbroek, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 20
Thirdhand smoke associations with the gut microbiomes of infants admitted to a neonatal intensive care unit: An observational study
Thomas F. Northrup, Angela L. Stotts, Robert Suchting, et al.
Environmental Research (2021) Vol. 197, pp. 111180-111180
Open Access | Times Cited: 20
Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans
William W. Stoops, Justin C. Strickland, Kevin W. Hatton, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 220, pp. 173466-173466
Open Access | Times Cited: 15
Introduction to the Special Issue: “Making orexin-based therapies for addiction a reality: What are the steps from here?”
Morgan H. James, Gary Aston‐Jones
Brain Research (2020) Vol. 1731, pp. 146665-146665
Open Access | Times Cited: 22
Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking
Theresa E. Bjorness, Robert Greene
Pharmacology Biochemistry and Behavior (2021) Vol. 206, pp. 173194-173194
Open Access | Times Cited: 19
Insomnia and the Orexinergic Pathway in the Link with Psychopathology: Effects of DORAs in Insomnia Comorbid with Mental Disturbances
Laura Palagini, Pierre A. Geoffroy, Gaspare Alfì, et al.
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 119-131
Closed Access | Times Cited: 2
Objective and subjective measurement of sleep in people who use substances: Emerging evidence and recommendations from a systematic review
Heather E. Webber, Jessica C. Badawi, Joy M. Schmitz, et al.
Journal of Sleep Research (2024)
Closed Access | Times Cited: 2
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
Taro Kishi, Michinori Koebis, Michiko SUGAWARA, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Patient-reported sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review
Andrew S. Huhn, Jennifer D. Ellis, Kelly E. Dunn, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109508-109508
Open Access | Times Cited: 12
Objective sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review
Andrew S. Huhn, Kelly E. Dunn, Jennifer D. Ellis, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109509-109509
Open Access | Times Cited: 11
Decreased cocaine demand following contingency management treatment
Jin H. Yoon, Robert Suchting, Constanza de Dios, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108883-108883
Closed Access | Times Cited: 14
Orexin/hypocretin and major psychiatric disorders
Chin-Chuen Lin, Tiao‐Lai Huang
Advances in clinical chemistry (2022), pp. 185-212
Closed Access | Times Cited: 10
The sensation seeking trait confers a dormant susceptibility to addiction that is revealed by intermittent cocaine self-administration in rats
Shayna L. O’Connor, Gary Aston‐Jones, Morgan H. James
Neuropharmacology (2021) Vol. 195, pp. 108566-108566
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top